Fig. 2
From: ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer
Prognostic value of PRICKLE1-interacting small G-protein regulators in TNBC and cooperation between PRICKLE1 and ECT2 as poor-prognosis markers. a Boxplot of GEF/GAP regulators expression across breast cancers. b Boxplot of GEF/GAP regulators expression across triple negative (TN) vs. HR+/HER2− or HER2+ breast cancers. c Kaplan–Meier curves of metastasis-free survival among breast cancers patients according to overexpression (up) vs. underexpression (down) of GEF/GAP metagene mRNA. d Kaplan–Meier curves of metastasis-free survival among non-TNBC patients for GEF/GAP metagene mRNA expression. Kaplan–Meier curves of metastasis-free survival among TNBC patients for e GEF/GAP metagene mRNA expression, f PRICKLE1 mRNA expression, g PRICKLE1 mRNA and GEF/GAP metagene expression, h ECT2 mRNA expression, and i PRICKLE1 and ECT2 mRNA expression
